🔗 Share this article

This year's Nobel Prize in medical science has been granted for transformative findings that illuminate how the body's defense network targets dangerous infections while sparing the healthy tissues.

Three esteemed researchers—from Japan Prof. Sakaguchi and US experts Dr. Brunkow and Fred Ramsdell—share this honor.

The work uncovered unique "sentinels" within the immune system that eliminate malfunctioning defense cells that could harming the body.

These findings are now enabling innovative therapies for immune disorders and cancer.

These winners will share a prize fund valued at 11 million SEK.

Crucial Findings

"The research has been essential for understanding how the immune system functions and why we do not all suffer from severe autoimmune diseases," commented the chair of the award panel.

This trio's studies explain a fundamental mystery: In what way does the defense system protect us from numerous infections while leaving our healthy cells intact?

Our immune system uses white blood cells that scan for signs of disease, including pathogens and germs it has not met before.

Such cells utilize detectors—known as receptors—that are generated by chance in a vast number of variations.

That provides the immune system the ability to combat a broad range of threats, but the unpredictability of the process unavoidably creates immune cells that can attack the host.

Protectors of the Immune System

Researchers earlier understood that a portion of these problematic defense cells were destroyed in the thymus—the site where immune cells develop.

This year's Nobel Prize recognizes the identification of regulatory T-cells—known as the immune system's "peacekeepers"—which patrol the body to neutralize any defenders that assault the body's own tissues.

We know that this process fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

The Nobel panel stated, "The findings have laid the foundation for a novel area of research and spurred the creation of new therapies, for instance for cancer and immune disorders."

In malignancies, T-regs prevent the body from fighting the tumor, so research are focused on lowering their quantity.

For self-attack disorders, experiments are testing boosting regulatory T-cells so the organism is no longer being harmed. A similar method could also be effective in minimizing the chances of transplanted organ failure.

Innovative Studies

Prof Sakaguchi, from Osaka University, performed experiments on rodents that had their immune gland extracted, causing autoimmune disease.

He showed that injecting defense cells from healthy animals could prevent the illness—implying there was a system for preventing immune cells from attacking the host.

Dr. Brunkow, affiliated with the Institute for Systems Biology in a US city, and Fred Ramsdell, now at a biotech firm in a California city, were investigating an inherited immune disorder in mice and humans that resulted in the identification of a genetic factor critical for how regulatory T-cells function.

"Their groundbreaking work has revealed how the body's defenses is kept in check by regulatory T cells, stopping it from mistakenly attacking the body's own tissues," said a leading biological science specialist.

"The research is a remarkable illustration of how fundamental biological research can have far-reaching consequences for public health."